about
Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13.Evaluation of lysine biosynthesis as an antifungal drug target: biochemical characterization of Aspergillus fumigatus homocitrate synthase and virulence studiesInvasive fungal infections in solid organ transplant recipients.Developments for improved diagnosis of bacterial bloodstream infections.Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTsAntimicrobial blue light inactivation of Candida albicans: In vitro and in vivo studies.Initial therapeutic strategy of invasive candidiasis for intensive care unit patients: a retrospective analysis from the China-SCAN study.Neonatal Candidiasis: New Insights into an Old Problem at a Unique Host-Pathogen InterfaceClinical analysis of deep cutaneous mycoses: a 12-year experience at a single institution.Sepsis induced immunosuppression: Implications for secondary infections and complications.Invasive fungal infections in the ICU: how to approach, how to treat.Indoor airborne fungal pollution in newborn units in Turkey.Opportunistic cutaneous fungal infections in the inpatient setting.Problems related to antifungal prescription: a qualitative study of the views of intensivists.Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.Primary deep cutaneous candidiasis caused by Candida duobushaemulonii in a 68-year-old man: the first case report and literature review.Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans.β-(1→6)-D-glucan secreted during the optimised production of exopolysaccharides by Paecilomyces variotii has immunostimulatory activity.Effect of ArtinM on Human Blood Cells During Infection With Paracoccidioides brasiliensis.
P2860
Q33870762-259E9E29-8892-4C3E-9C4B-B0583123F677Q33983108-7F8169BD-187F-4D95-A13C-4DC030A8EA9EQ34461693-D1E84F5D-DD68-4250-9B3C-FB54531A2B32Q35171979-69C704B4-0732-4445-A18A-22F1F8BA4942Q35515892-69FC55E6-7AF5-45EA-860A-C5E79456B9B0Q35933700-E8112D3F-9B53-40E5-BED0-355F18D22DD2Q36257873-F189A74F-A379-4C88-9D8E-234BA22423D8Q36462048-43CA39D1-5DBC-42AF-8651-C4BC5C0DA1CBQ38001158-F8F933A5-B45E-4F33-A2C3-C718F97BE37AQ38148132-E41C3149-2929-42F7-8853-1DF1A10380FBQ38180287-65FC57DC-945B-4802-A254-D1DB5B51156BQ40151306-1662EB2D-F606-4C06-A42B-7E6629ADC42EQ44936166-DD5973A3-1A62-4D1C-A48B-6AE87A02A979Q45895673-39FFBE3B-1E20-47C9-8009-465448952983Q46393306-07C1480A-D259-4CF2-BFF8-3606521912EFQ46492873-565F6EC9-B0CF-4942-88D2-409B443538F0Q47647577-18CE6152-1098-4214-9D5B-71CDE6A81BCEQ48125405-0592AA87-83B3-4341-AD59-662BC15CAF8AQ54205003-77B9D0AC-CE17-42F7-8F72-99D4527B4452
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Invasive fungal infections in the ICU.
@en
Invasive fungal infections in the ICU.
@nl
type
label
Invasive fungal infections in the ICU.
@en
Invasive fungal infections in the ICU.
@nl
prefLabel
Invasive fungal infections in the ICU.
@en
Invasive fungal infections in the ICU.
@nl
P2860
P356
P1476
Invasive fungal infections in the ICU.
@en
P2093
Shilpa Marwaha
Shmuel Shoham
P2860
P356
10.1177/0885066609355262
P577
2009-12-01T00:00:00Z